Introduction

KP Tissue, Inc. (TSX:KPT) is a holding company whose principal asset is an approximately 12.1% interest in Kruger Products, a leading manufacturer of tissue products in Canada and a growing player in the United States. Kruger Products sells well-known consumer brands such as Cashmere, Purex, SpongeTowels and Scotties, along with private label products and an Away-From-Home business serving commercial and institutional customers. KP Tissue's dividend is funded by distributions it receives from Kruger Products, so its sustainability depends on the operating partnership's cash flow, capital spending and debt levels. In 2026 the quarterly dividend rose to $0.21 per share from $0.18, a change management tied to the dividend's tax designation moving from eligible to non-eligible rather than to a step-change in earnings. With a dividend yield of approximately 6.95%, investors are asking whether the payout can be maintained as Kruger Products balances mill investments, pulp price swings and a softer Canadian consumer market.

Dividend Sustainability Analysis

Because KP Tissue holds a minority stake in Kruger Products, its ability to pay dividends rests on the distributions declared by the operating business. The structure provides a direct pass-through of cash, but it also means shareholders depend on decisions taken at the Kruger Products level, where Kruger Inc. is the controlling owner.

Operating performance has improved. In the second quarter of 2026, Kruger Products reported higher revenue and a substantial increase in adjusted EBITDA, with margins expanding as mill performance improved and pulp costs eased. Management guided to third-quarter adjusted EBITDA broadly in line with the second quarter, suggesting a stable near-term cash flow base.

Leverage is the key area to watch. Net debt at Kruger Products was close to $1 billion at mid-2026, with leverage of about 2.9x trailing adjusted EBITDA. That level is manageable for a consumer staples producer, but it limits flexibility if margins compress or capital projects run over budget.

It is also important to understand that the recent dividend increase was linked to a tax designation change, intended to keep after-tax value roughly neutral for many shareholders. Investors should therefore not interpret the higher cash amount as evidence of a materially stronger coverage position. Overall, the dividend appears supported by improved operating cash flow, but its margin of safety depends on pulp costs and capital discipline.

Dividend Outlook

The dividend outlook appears stable, though growth beyond the recent adjustment is likely to be limited. KP Tissue has historically maintained a consistent quarterly payout through varying operating conditions, reflecting the defensive nature of tissue demand.

Future dividend capacity will depend on Kruger Products' ability to sustain margin improvements, fund its capital program and keep leverage within comfortable bounds. Planned 2026 capital spending includes work tied to future U.S. through-air-dried capacity, and a major greenfield project would require significant investment.

If pulp prices rise as some industry analysts expect in late 2026 or early 2027, or if Canadian market softness persists, margins could narrow and distribution growth could pause. The outlook therefore favours dividend stability over meaningful increases.

Key Growth Drivers

KP Tissue possesses several structural growth drivers that could enhance long-term shareholder value. The most important is Kruger Products' expansion in the United States, where higher consumer and Away-From-Home volumes have been offsetting softer Canadian sales.

Premium through-air-dried tissue capacity represents a significant long-term opportunity. Kruger Products continues to evaluate a new TAD facility in the western United States, which could support growth in premium bathroom tissue and paper towels, although the decision has been delayed by site complexity and economic uncertainty.

Operational efficiency gains are another driver. The Memphis converting line has ramped up ahead of plan, and better mill performance has contributed to recent margin expansion.

Strong brand equity in Canada supports pricing power. Cashmere, Purex and SpongeTowels are leading household brands, and management is investing in a share recovery plan to address consumer trade-down.

The defensive nature of tissue demand also supports long-term stability, since household and commercial consumption tends to remain steady regardless of economic conditions.

Potential Catalysts

Several catalysts could positively influence future shareholder returns. A final decision on a western U.S. TAD facility, with clear financing and return expectations, would provide visibility on the next leg of growth.

Continued margin strength in upcoming quarters would reinforce confidence in distribution coverage.

Successful execution of the Canadian share recovery plan could restore domestic volume growth.

Deleveraging at Kruger Products would improve financial flexibility and reduce risk to the dividend.

Stable or lower pulp prices for longer than expected would support profitability and cash generation.

Key Risks to Consider

Despite its defensive profile, investors should recognize several important risks. Pulp price volatility is a primary concern, as pulp is a major input cost and analysts expect prices to rise in the coming quarters.

Structural dependence on Kruger Products is significant. KP Tissue holds a minority interest and has limited control over capital allocation, distribution policy or strategic decisions.

Leverage and capital intensity could become a burden if a large greenfield TAD project proceeds while margins weaken.

Competitive pressure from private label products and larger global tissue producers can limit pricing power, particularly when consumers trade down.

Currency exposure arises from growing U.S. operations and U.S. dollar-linked input costs, which can affect reported results.

Energy, freight and labour cost inflation can also weigh on margins, as elevated freight and SG&A costs showed in 2026.

Valuation Perspective

From a valuation standpoint, KP Tissue should be evaluated using EV to EBITDA for Kruger Products, free cash flow after capital spending, leverage and dividend yield, rather than KP Tissue's own reported earnings, which are affected by its equity accounting structure.

A dividend yield of approximately 6.95% is attractive for a consumer staples business, though part of that premium reflects the holding company structure, minority position, leverage and pulp exposure.

The valuation case improves if margin gains prove durable and capital projects deliver attractive returns. Conversely, rising input costs or a costly expansion program could keep the shares at a discount.

Technical Analysis and Key Levels

From a technical perspective, investors should monitor whether the shares maintain a sequence of higher lows, with the 50-day and 200-day moving averages serving as important gauges of medium- and long-term trend direction.

Strong volume accompanying advances after favourable quarterly results or TAD project updates would reinforce bullish momentum. Conversely, failures near prior resistance on declining volume, particularly as pulp prices rise, could indicate weakening momentum.

Long-term income investors may benefit from accumulating positions during technically oversold periods rather than trading short-term fluctuations.

Investment Outlook

KP Tissue, Inc. offers investors indirect exposure to Kruger Products, a leading Canadian tissue maker with growing U.S. operations and well-recognized household brands. Improved mill performance, lower pulp costs and higher U.S. volumes have strengthened recent results, and the defensive nature of tissue demand supports reliable cash flow. The recent dividend increase reflects a tax designation change rather than a fundamental shift, so investors should judge sustainability on Kruger Products' cash generation and leverage. Risks include pulp price volatility, the capital needs of a potential western U.S. TAD facility, minority ownership and Canadian market softness. For income investors seeking a consumer staples holding with an attractive yield, KP Tissue may offer a balanced opportunity. Future returns will likely depend on margin durability, disciplined capital allocation and successful U.S. expansion.